• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Introduction to 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide (CAS No. 306937-23-5) and Its Emerging Applications in Chemical Biology

The compound 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide (CAS No. 306937-23-5) represents a significant advancement in the field of chemical biology, particularly in the design and development of novel heterocyclic scaffolds for therapeutic applications. Pyrazole derivatives have long been recognized for their diverse pharmacological properties, and the introduction of substituents such as tert-butyl and methyl groups further enhances its potential as a pharmacophore. This introduction delves into the structural characteristics, synthetic pathways, and recent research highlighting its applications in drug discovery and molecular biology.

Structurally, 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide is characterized by a pyrazole core substituted with a tert-butyl group at the 1-position and a methyl group at the 5-position, with a carbohydrazide moiety at the 3-position. This unique arrangement imparts distinct electronic and steric properties, making it an attractive candidate for modulating biological targets. The tert-butyl group enhances lipophilicity and metabolic stability, while the carbohydrazide functionality provides a versatile handle for further derivatization, enabling the synthesis of more complex molecules.

In recent years, there has been growing interest in leveraging pyrazole derivatives for their potential in treating various diseases, including cancer, inflammation, and infectious disorders. The carbohydrazide group in 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide has been particularly explored for its ability to form covalent bonds with biological targets, such as kinases and proteases. This covalent interaction can lead to potent inhibition of target enzymes, making it a promising lead compound for drug development.

One of the most compelling aspects of this compound is its role in preclinical studies investigating novel therapeutic strategies. Researchers have utilized 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide as a scaffold to develop inhibitors targeting specific enzymes implicated in disease pathways. For instance, studies have demonstrated its efficacy in inhibiting Janus kinases (JAKs), which are overexpressed in various inflammatory conditions and cancers. The ability of the compound to selectively modulate these kinases without significant off-target effects underscores its potential as a therapeutic agent.

Furthermore, the synthesis of derivatives from 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide has opened new avenues for drug discovery. By modifying the substituents on the pyrazole ring or introducing additional functional groups, researchers can fine-tune the pharmacological properties of the compound. This modular approach allows for rapid screening of libraries of derivatives to identify compounds with enhanced potency, selectivity, and pharmacokinetic profiles.

The carbohydrazide moiety also facilitates bioconjugation strategies, enabling the development of prodrugs or targeted delivery systems. For example, researchers have explored linking this compound to antibodies or nanoparticles to enhance its delivery to specific tissues or tumors. Such advancements highlight its versatility as a building block in medicinal chemistry.

Recent computational studies have further illuminated the mechanistic aspects of 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide interactions with biological targets. Molecular dynamics simulations have revealed that the compound binds tightly to its target enzymes through hydrogen bonding networks involving the carbohydrazide group and other polar residues. These insights have guided rational modifications to improve binding affinity and reduce toxicity.

In conclusion, 1-(tert-Butyl)-5-methyl-1H-pyrazole-3-carbohydrazide (CAS No. 306937-23-5) represents a valuable tool in chemical biology and drug discovery. Its unique structural features and functional versatility make it an excellent scaffold for developing novel therapeutics targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in shaping future treatments across multiple therapeutic areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)